Compared to Black and Asian people, white and Hispanic people with Alzheimer’s disease and related dementias were more likely to be diagnosed with symptoms like depression and agitation, according to a new study from the USC Schaeffer Center for Health Policy & Economics.

White and Hispanic people with these diagnoses were also most likely to be prescribed central nervous system (CNS) active drugs, including antidepressants, antipsychotics and anticonvulsants. Yet, these drugs have been associated with higher risk of falls, cardiovascular events, hospitalization and death, according to the study published today in the Journal of Alzheimer’s Disease.

To read the full story, click here.